Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Has announcements × Low-grade Glioma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 3 Hematologic Neoplasms 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Leukemia, Biphenotypic, Acute 2 Leukemia 2 von Hippel-Lindau Disease 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thoracic Neoplasms 1 Solid Tumors 1 Sarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Myelodysplastic Syndromes 1 Metastatic Urothelial Cancer 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04775485 2025-04-10

FIREFLY-1

Day One Biopharmaceuticals, Inc.

Phase 2 Recruiting

141 enrolled 1 FDA

CNSOther solid neoplasm

Low-grade Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡